(Q44154788)

30 November 2017

Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study (English)

1 reference

30 November 2017

1 reference

Lennox-Gastaut sindrome

1 reference

Giangennaro Coppola

1

1 reference

30 November 2017

Graziella Caliendo

2

1 reference

30 November 2017

Pierangelo Veggiotti

3

1 reference

30 November 2017

Antonino Romeo

4

1 reference

30 November 2017

Gaetano Tortorella

5

1 reference

30 November 2017

Pasquale De Marco

6

1 reference

30 November 2017

Antonio Pascotto

7

1 reference

30 November 2017

language of work or name

1 reference

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

51

1 reference

30 November 2017

1-2

1 reference

30 November 2017

147-153

1 reference

The value of partial sleep deprivation as a routine measure in pediatric electroencephalography.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Topiramate in intractable childhood onset epilepsy--a cautionary note

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

A pilot study of topiramate in the treatment of infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Neurotrophin-3 levels in cerebrospinal fluid from children with bacterial meningitis, viral meningitis, or encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

A pilot study of topiramate in children with Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Antiepileptic drug-induced worsening of seizures in children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Topiramate for intractable childhood epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Topiramate in the treatment of severe myoclonic epilepsy in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Antiepileptic drugs as a cause of worsening seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Clinical experiences with topiramate in children with intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Topiramate for drug-resistant epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Paroxysmal tonic upgaze: physiopathological considerations in three additional cases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900103-1

7 January 2021

10.1016/S0920-1211(02)00103-1

Identifiers

DOI

1 reference

30 November 2017

1 reference